Financial reports
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
19 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
10-K
2021 FY
Annual report
1 Mar 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
Current reports
8-K
Regulation FD Disclosure
4 Apr 24
8-K
Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results
6 Mar 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Feb 24
8-K/A
Cost Associated with Exit or Disposal Activities
24 Jan 24
8-K
Invitae Completes Sale of Reproductive Health Assets to Natera
22 Jan 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
8-K/A
Cost Associated with Exit or Disposal Activities
11 Jan 24
8-K
Cost Associated with Exit or Disposal Activities
14 Dec 23
8-K
Entry into a Material Definitive Agreement
11 Dec 23
Registration and prospectus
25-NSE
Exchange delisting
21 Feb 24
424B2
Prospectus for primary offering
10 Aug 23
424B2
Prospectus for primary offering
10 Aug 23
POS AM
Prospectus update (post-effective amendment)
9 Aug 23
POS AM
Prospectus update (post-effective amendment)
9 Aug 23
424B3
Prospectus supplement
24 Apr 23
S-3
Shelf registration
17 Mar 23
POS AM
Prospectus update (post-effective amendment)
1 Mar 23
POS AM
Prospectus update (post-effective amendment)
28 Feb 23
S-8
Registration of securities for employees
28 Feb 23
Proxies
DEFA14A
Additional proxy soliciting materials
19 Apr 23
DEF 14A
Definitive proxy
19 Apr 23
PRE 14A
Preliminary proxy
3 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 22
DEF 14A
Definitive proxy
21 Apr 22
PRE 14A
Preliminary proxy
4 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEF 14A
Definitive proxy
28 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
Other
EFFECT
Notice of effectiveness
10 Aug 23
EFFECT
Notice of effectiveness
10 Aug 23
EFFECT
Notice of effectiveness
24 Apr 23
CORRESP
Correspondence with SEC
19 Apr 23
UPLOAD
Letter from SEC
22 Mar 23
SEC STAFF
SEC staff action: Order
30 Oct 20
UPLOAD
Letter from SEC
30 Oct 20
CORRESP
Correspondence with SEC
28 Sep 20
SEC STAFF
SEC staff action: Order
15 Sep 20
UPLOAD
Letter from SEC
14 Sep 20
Ownership
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Nikko Asset Management Americas, Inc.
13 Feb 24
SC 13G/A
Sumitomo Mitsui Trust Holdings, Inc.
5 Feb 24
SC 13G/A
ARK Investment Management LLC
29 Jan 24
SC 13G/A
BlackRock Inc.
29 Jan 24
4
Robert L Nussbaum
21 Dec 23
4
Thomas Brida
21 Dec 23
4
David Sholehvar
14 Nov 23
3
David Sholehvar
14 Nov 23
4
Thomas Brida
20 Oct 23